Reading through the financials again and trying to make sense of the Dear friendo letters, quarterlies, news releases and the published financials
can someone explain the disconnect that seems to exist?
The year end financials read:
Revenue $ 49,183 $ on total operating expenses 4,972,932
Net loss for the year $ (4,871,937)
Yet the second quarter financials read:
- Significant sales to two key centres in Europe, including the largest heart center in Germany, Deutsches Herzzentrum der Charit (DHZC), German Heart Center, in Berlin, Germany and to Medical Center – University of Freiburg im Breisgau, Germany through the efforts of Ventripoint’s European Distributor, Angiopro GmbH.
- The Company recorded deferred sales for the six months ended June 30, 2023, of $71,986. This will be recorded as revenue when the clients accept the units.
‘So the year end sales were down 30% over 6 months as 49k was recorded yet 71k was indicated 6 months ago???
What happenned
Were the touted a German sales rejected/not approved?
were ther no sales recorded over the last 6 months?
if so....
How secure are the Duke sales?
I don’t see the original “sales” were recorded since the math doesn’t add up to me can someone explain
Also how can you spend almost 5 million in operating expenses yet only receive 10% of that in gross sales be sustainable ?
all imo
my analysis'fwiw'
do your own dd